EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/ YAP pathway

Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li iD, Chao He iD

Cancer Science · 2024

DOI: 10.1111/cas.16134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Bo Shu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ribonucleoproteins, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hunan Provincial Natural Science Foundation of China, Changsha Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer is the sixth most common cancer and the third leading cause of cancer‐related death globally. Despite efforts being made in last two decades in cancer diagnosis and treatment, the 5‐year survival rate of liver cancer remains extremely low. TRIM21 participates in cancer metabolism, glycolysis, immunity, chemosensitivity and metastasis by targeting various substrates for ubiquitination. TRIM21 serves as a prognosis marker for human hepatocellular carcinoma (HCC), but the mechanism by which TRIM21 regulates HCC tumorigenesis and progression remains elusive. In this study, we demonstrated that TRIM21 protein levels were elevated in human HCC. Elevated TRIM21 expression was associated with HCC progression and poor survival. Knockdown of TRIM21 in HCC cell lines significantly impaired cell growth and metastasis and enhanced sorafenib‐induced toxicity. Mechanistically, we found that knockdown of TRIM21 resulted in cytosolic translocation and inactivation of YAP. At the molecular level, we further identified that TRIM21 interacted and induced ubiquitination of MST1, which resulted in MST1 degradation and YAP activation. Knockdown of MST1 or overexpression of YAP reversed TRIM21 knockdown‐induced impairment of HCC growth and chemosensitivity. Taken together, the current study demonstrates a novel mechanism that regulates the Hippo pathway and reveals TRM21 as a critical factor that promotes growth and chemoresistance in human HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRibonucleoproteinsSignal TransductionAnimalsFemaleHumansMaleMiceAdaptor Proteins, Signal TransducingCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGene Knockdown TechniquesPhosphoproteinsProto-Oncogene ProteinsSorafenibTranscription FactorsUbiquitinationYAP-Signaling Proteins

Stichwörter der Autor:innen

E3 ubiquitin ligasechemosensitivitysorafenibtherapeutic target

Substanzen

Adaptor Proteins, Signal TransducingPhosphoproteinsProto-Oncogene ProteinsRibonucleoproteinsSorafenibTranscription FactorsYAP-Signaling Proteins

Autor:innen und Institutionen

  • Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Surgical Operation, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Neurosurgery, Brain Hospital of Hunan Province (The Second People's Hospital of Human Province), Changsha, Hunan, China.
  • Department of Pharmacy, Hunan Normal University School of Medicine, Changsha, Hunan, China.

ORCID-Profile: Zhuan Li, Chao He

Förderung

  • Hunan Provincial Natural Science Foundation of China
  • Changsha Municipal Natural Science Foundation

Zitieren

APA

Shu, B., Zhou, Y., Lei, G., Peng, Y., Ding, C., Li, Z., & He, C. (2024). TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/ YAP pathway. Cancer Science. https://doi.org/10.1111/cas.16134

Vancouver

Shu B, Zhou Y, Lei G, Peng Y, Ding C, Li Z, et al. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/ YAP pathway. Cancer Science. 2024. doi:10.1111/cas.16134

BibTeX
@article{Shu2024,
  author = {Shu, Bo and Zhou, Yingxia and Lei, Guoqiong and Peng, Yu and Ding, Cong and Li, Zhuan and He, Chao},
  title = {TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/ YAP pathway},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16134}
}
Kostenlos starten →